Cancer Drug Antitrust | Courthouse News Service
Friday, December 1, 2023 | Back issues
Courthouse News Service Courthouse News Service

Cancer Drug Antitrust

Merck, Cancer Research Technology, and Sanofi-Aventis manipulated the patent process and filed sham litigation to extend their monopoly over a brain cancer drug, Temodar, an antitrust class action claims in Delaware Federal Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.